Structural and spectroscopic traits of low- and high-concentration Tm 3+ -sensitized Ho 3+ :CaF 2 crystals for efficient broadband ∼2 μm emission
CrystEngComm · 2026
DOI: 10.1039/d6ce00518g ↗Kurz gefasst
Fachartikel in der Zeitschrift CrystEngComm, 2026. Verfasst von Yixiang Huang und 7 weiteren Autor:innen. Die Arbeit nennt 79 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Ministry of Industry and Information Technology of the People's Republic of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
High-quality 1 and 3 at% Tm 3+ -sensitized 7 at% Ho 3+ :CaF 2 crystals were grown. The 1 at% Tm 3+ -sensitized crystal exhibits a 167 nm emission bandwidth around 2 μm, ∼23 ms lifetime, and enhanced emission under 1150 nm pumping.
Förderung
- National Key Research and Development Program of China
- Ministry of Industry and Information Technology of the People's Republic of China
- National Natural Science Foundation of China
- Fujian Provincial Institute of Research on the Structure of Matter, Chinese Academy of Sciences
Zitieren
APA
Huang, Y., Zheng, L., Zhu, Z., Huang, Y., Tu, C., Lakshminarayana, G., Wang, H., & Wang, Y. (2026). Structural and spectroscopic traits of low- and high-concentration Tm 3+ -sensitized Ho 3+ :CaF 2 crystals for efficient broadband ∼2 μm emission. CrystEngComm. https://doi.org/10.1039/d6ce00518g
Vancouver
Huang Y, Zheng L, Zhu Z, Huang Y, Tu C, Lakshminarayana G, et al. Structural and spectroscopic traits of low- and high-concentration Tm 3+ -sensitized Ho 3+ :CaF 2 crystals for efficient broadband ∼2 μm emission. CrystEngComm. 2026. doi:10.1039/d6ce00518g
BibTeX
@article{Huang2026,
author = {Huang, Yixiang and Zheng, Longxing and Zhu, Zhaojie and Huang, Yizhi and Tu, Chaoyang and Lakshminarayana, G. and Wang, Hongyan and Wang, Yan},
title = {Structural and spectroscopic traits of low- and high-concentration Tm 3+ -sensitized Ho 3+ :CaF 2 crystals for efficient broadband ∼2 μm emission},
journal = {CrystEngComm},
year = {2026},
doi = {10.1039/d6ce00518g}
}
EUVIMED